Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Injection Sekucinumab in Erythrodermic Psoriasis

NCT06801028 is registered in ClinicalTrials.gov with Jinnah Postgraduate Medical Centre as lead sponsor.

NCT NCT06801028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06801028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Injection Sekucinumab in Erythrodermic Psoriasis
Lead sponsor
Jinnah Postgraduate Medical Centre
Phase
Observational
Overall status
Not yet recruiting
Start date
January 20, 2025
Completion date
May 30, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythrodermic psoriasis